Biotech News

4DMT to Participate in Upcoming Investor Conferences

4D Molecular Therapeutics, Inc. (FDMT)4D Molecular Therapeutics, Inc.Company update

4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that management will present and participate in one-on-one meetings at upcoming investor conferences in November and December:

Related news

4D Molecular Therapeutics, Inc.

Genetic Medicines Company 4D Molecular Therapeutics develops genetic medicines using an engineered AAV vector platform known as Therapeutic Vector Evolution. The technology is designed to select vectors for specific tissues and routes of administration rather than relying only on naturally occurring viral capsids. 4D-150 Retinal...

Recent company news

Stock data

Close
10.72 USD
Market cap
484.6M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States